Therapeutic Note(s)

Government of Ontario Logo
2.5mg Tab (SAXAGLIPTIN)
Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have: . Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea.